• Home
  • Top News
  • Entertainment
  • Economy
  • World
  • Sports
  • Contact Form
Facebook Twitter Instagram
Facebook Twitter Instagram
mazmessenger
Button
  • Home
  • Top News
  • Entertainment
  • Economy
  • World
  • Sports
  • Contact Form
mazmessenger
Home ยป Danaher Acquires Abcam in $5.7 Billion Deal
Business

Danaher Acquires Abcam in $5.7 Billion Deal

Adrian GarrettBy Adrian GarrettAugust 30, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Danaher Corp, one of the world’s largest suppliers of medical and diagnostic tools, has announced its plans to acquire protein consumables manufacturer Abcam Plc in a $5.7 billion deal. The acquisition will be an all-cash transaction, including debt.

The primary objective behind this acquisition is to broaden Danaher’s portfolio of products and services. By expanding their offerings, the company aims to counteract the sluggish demand they have been experiencing for their products from smaller biotech firms.

Notably, Danaher has been revising its annual sales growth forecast multiple times this year due to these slow market conditions. The purchase of Abcam is expected to provide a major boost to the company’s prospects, as it will allow Danaher to tap into Abcam’s expertise in manufacturing and supplying protein consumables used in medical research, such as antibodies and reagents.

Experts believe that incorporating Abcam’s higher-margin business into Danaher’s operations will prove beneficial in the long run. Abcam had engaged with 20 potential buyers before ultimately settling on Danaher as the ideal partner for this deal.

See also  Gas prices surge 60 cents per gallon this year, taking a toll on inflation-weary drivers

The acquisition is scheduled to conclude in mid-2024 and is projected to contribute to Danaher’s adjusted earnings per share by 20 cents in the first full year after its completion. In terms of the financial arrangements, Danaher has offered $24 per share in cash, representing a 2.7% premium to Abcam’s last closing price.

Following the announcement, Abcam’s shares experienced a slight decline of about 3.1%, whereas Danaher’s shares rose by 1.8%. This acquisition is part of Danaher’s overarching strategy to enhance its market presence through strategic acquisitions. It follows previous purchases of Aldevron and General Electric Co’s biopharma solution business.

By expanding its product portfolio and solidifying its position within the medical and diagnostic tools sector, Danaher is positioning itself for continued success and growth in the years to come.

Adrian Garrett

“Zombie enthusiast. Subtly charming travel practitioner. Webaholic. Internet expert.”

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Adrian Garrett

"Zombie enthusiast. Subtly charming travel practitioner. Webaholic. Internet expert."

Related Posts

Drugmakers Agree to Medicare Drug Price Negotiations โ€“ Heres What Happens Next

October 3, 2023

Mazmessenger: Blue Apron Stock Skyrockets 130% Following Surprising Sale Announcement

September 30, 2023

Automakers express growing frustration as UAW negotiations progress slowly, amid looming strike deadline

September 29, 2023

Leave A Reply Cancel Reply

Recent Posts

  • Mazmessenger – Aquarius Daily Horoscope Today: October 4, 2023 Reveals Promising Outcomes
  • Mazmessenger: Honoring Refugees Lost off Italy a Decade Ago Amidst Ongoing Crisis
  • Inside Deion Sanders First Month of Games at Colorado
  • Pope Francis Suggests Blessings for Same-Sex Unions Amidst Conservative Cardinals Response
  • Mali Deploys Troops to Northeastern Rebel Stronghold

Recent Comments

No comments to show.

Archives

  • October 2023
  • September 2023
  • August 2023
  • July 2023

Categories

  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
  • Top News
  • World
Facebook Twitter Instagram Pinterest
  • Privacy Policy
  • DMCA
  • Contact Form
  • About Us
© 2023 ThemeSphere. Designed by ThemeSphere.

Type above and press Enter to search. Press Esc to cancel.